loader
Please Wait
Applying Filters...

What is Route Evaluation & Development? A CDMO that can optimize your API synthesis process early during technology transfer will reduce the risk of project delay or failure. That will also help your molecule run more efficiently in their plant. And time is money. Most medicinal chemists design novel active pharmaceutical ingredients (APIs) to secure a patent and IP protection, not to create a scalable production process. That makes sense. They are racing against the clock, running through fail

Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1EUROAPI

02 1Aspen API

03 1Cayman Chemical Company Inc

04 1PMC Isochem

05 1M2i Group

06 1Aesica Pharmaceuticals Limited

07 1Bellen Chemistry

08 1Bioindustria L.I.M. Spa

09 1Biolink LifeSciences

10 1CARBOGEN AMCIS AG

11 1CLEARSYNTH LABS LIMITED

12 1Cambrex Corporation

13 1Curia

14 1Eurofins CDMO

15 1Evotec

16 1Nanjing Dorra Pharmaceutical Technology Co.,Ltd

17 1POLYPHARMA TECH & SCIENCES

18 1Prague Scientific

19 1Siegfried AG

20 1UQUIFA

filter clear-filterReset all filters

PharmaCompass